Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease of beta-endorphin in the brain of rats following nitrous oxide withdrawal.

M R Dzoljic1, J Haffmans, J Rupreht

  • 1Department of Pharmacology, Faculty of Medicine and Health Sciences, Erasmus University, Rotterdam, The Netherlands.

Drug Metabolism and Drug Interactions
|January 1, 1991
PubMed
Summary

Nitrous oxide (N2O) exposure did not alter beta-endorphin levels. However, N2O withdrawal significantly decreased beta-endorphin in rats, potentially explaining withdrawal symptoms and therapeutic effects of meperidine.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glucocorticoid and mineralocorticoid receptor polymorphisms and clinical characteristics in bipolar disorder patients.

Psychoneuroendocrinology·2011
Same author

Antagonism of gamma-hydroxybutyrate-induced hypersynchronization in the ECoG of the rat by anti-petit mal drugs.

Neuroscience letters·2009
Same author

[Distraction osteogenesis in the head and neck region].

Nederlands tijdschrift voor geneeskunde·2006
Same author

Keuskamp and the Amsterdam Infant Ventilator.

Anaesthesia·2006
Same author

[Physostigmine for the immediate treatment of a patient with the central anticholinergic syndrome induced by cocaine cut with atropine].

Nederlands tijdschrift voor geneeskunde·2005
Same author

[Fever, large eyes and confusion; the anticholinergic syndrome].

Nederlands tijdschrift voor geneeskunde·2003

Area of Science:

  • Neuroscience
  • Anesthesiology
  • Pharmacology

Background:

  • Nitrous oxide (N2O) is a widely used anesthetic agent.
  • The neurobiological effects of N2O, particularly concerning endogenous opioid systems like beta-endorphin, require further elucidation.
  • Understanding N2O withdrawal mechanisms is crucial for managing patient recovery and potential adverse effects.

Purpose of the Study:

  • To investigate the impact of acute and chronic nitrous oxide (N2O) exposure and subsequent withdrawal on beta-endorphin levels in the rat brain.
  • To explore the potential role of beta-endorphin changes in N2O withdrawal phenomena and associated behaviors.

Main Methods:

  • Rats were exposed to N2O for acute (25 min) and chronic (48 h) durations.
  • Beta-endorphin levels were measured in whole brain, brain stem, and subcortex following N2O exposure and during withdrawal.

Related Experiment Videos

  • Comparative analysis of beta-endorphin levels under different exposure and withdrawal conditions.

    • Main Results:

    • Acute and chronic N2O exposure did not significantly alter whole rat brain beta-endorphin levels.
    • A significant decrease in beta-endorphin was observed in the whole brain, brain stem, and subcortex during withdrawal from chronic N2O exposure.
    • This decrease is hypothesized to be linked to stress associated with drug withdrawal.

    Conclusions:

    • N2O withdrawal, not exposure, significantly impacts central beta-endorphin levels.
    • Reduced beta-endorphin during N2O withdrawal may modulate neurotransmitter balance, neuronal excitability, and withdrawal behaviors.
    • This finding may explain the N2O-excitatory syndrome post-anesthesia and the efficacy of meperidine in mitigating these withdrawal effects in humans.